ATE32430T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE32430T1
ATE32430T1 AT81300867T AT81300867T ATE32430T1 AT E32430 T1 ATE32430 T1 AT E32430T1 AT 81300867 T AT81300867 T AT 81300867T AT 81300867 T AT81300867 T AT 81300867T AT E32430 T1 ATE32430 T1 AT E32430T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
gamma
linolenic acid
thioproline
dihomo
Prior art date
Application number
AT81300867T
Other languages
English (en)
Inventor
David Frederick Horrobin
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Application granted granted Critical
Publication of ATE32430T1 publication Critical patent/ATE32430T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT81300867T 1980-03-14 1981-03-03 Pharmazeutische zusammensetzungen. ATE32430T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8008764 1980-03-14
EP81300867A EP0037175B1 (de) 1980-03-14 1981-03-03 Pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE32430T1 true ATE32430T1 (de) 1988-02-15

Family

ID=10512112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81300867T ATE32430T1 (de) 1980-03-14 1981-03-03 Pharmazeutische zusammensetzungen.

Country Status (7)

Country Link
EP (1) EP0037175B1 (de)
JP (1) JPS56142214A (de)
AT (1) ATE32430T1 (de)
AU (1) AU546350B2 (de)
CA (1) CA1157773A (de)
DE (1) DE3176644D1 (de)
IE (1) IE53332B1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU538186B2 (en) * 1980-03-07 1984-08-02 Scotia Holdings Plc Prostaglandin precursors
DE3366506D1 (en) * 1982-03-01 1986-11-06 Efamol Ltd Pharmaceutical composition
AU1933383A (en) * 1982-09-22 1984-03-29 Sentrachem Limited Composition of prostaglandins for prevention of cancer
GB8506027D0 (en) * 1985-03-08 1985-04-11 Efamol Ltd Pharmaceutical & dietary compositions
GB8603621D0 (en) * 1986-02-14 1986-03-19 Habib N Modifying lipid structure of cell membranes
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
US5599840A (en) * 1986-11-26 1997-02-04 Bar Ilan University Physiologically active and nutritional composition
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
JPS63258816A (ja) * 1987-04-16 1988-10-26 Nippon Oil & Fats Co Ltd 抗癌剤組成物
IL91802A (en) * 1988-10-27 1994-05-30 Univ Bar Ilan Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy
CA2010511A1 (en) * 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
WO1992000066A1 (en) * 1990-06-25 1992-01-09 The Du Pont Merck Pharmaceutical Company Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
FR2704390B1 (fr) * 1993-04-29 1995-06-02 Boiron Complément nutritionnel absorbable per-os destiné à améliorer la peau.
GB9403855D0 (en) 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US6331567B1 (en) 1997-06-13 2001-12-18 Mars Uk Limited Edible composition containing zinc and linoleic acid
GB9712420D0 (en) * 1997-06-13 1997-08-13 Mars Uk Ltd Food
US20020123469A1 (en) * 2000-10-31 2002-09-05 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
GB2470001A (en) * 2009-05-05 2010-11-10 Alaa Hussein Al-Darraji Use of gamma linolenic acid in the treatment and diagnosis of cancer
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
KR102001957B1 (ko) * 2013-02-25 2019-07-19 한국화학연구원 8-하이드록시-7-아이오도-5-퀴놀린설폰산 또는 1-(2,4,6-트리하이드록시페닐)프로판-1-온을 유효성분으로 포함하는 암 치료 또는 예방용 약학적 조성물
KR102391827B1 (ko) 2014-06-04 2022-04-27 디에스 바이오파마 리미티드 Dgla를 포함하는 약제학적 조성물 및 그의 용도
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1592M (fr) * 1961-07-28 1962-12-03 Aschaffenburger Zellstoffwerke Agents d'activation de cellules kératinogenes de l'organisme.
FR3184M (fr) * 1963-02-04 1965-03-15 Sogespar S A Nouveau médicament a base d'acide thiazolidine carboxylique.
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
BE867787A (fr) * 1978-06-02 1978-12-04 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
US4384001A (en) * 1978-12-21 1983-05-17 Gosalvez Mario Treatment of tumors with thiazolidine-4-carboxylic acid
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids

Also Published As

Publication number Publication date
EP0037175B1 (de) 1988-02-10
AU546350B2 (en) 1985-08-29
DE3176644D1 (en) 1988-03-17
EP0037175A1 (de) 1981-10-07
JPS56142214A (en) 1981-11-06
IE810441L (en) 1981-09-14
AU6834781A (en) 1981-09-17
CA1157773A (en) 1983-11-29
IE53332B1 (en) 1988-10-26

Similar Documents

Publication Publication Date Title
ATE32430T1 (de) Pharmazeutische zusammensetzungen.
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
IL64885A (en) 3,20-dioxo-1,4-pregnadiene-17alpha-ol-17-aromatic heterocyclic esters,their preparation and pharmaceutical compositions containing them
SE8700498D0 (sv) Novel pharmaceologically active compounds
FI840748A0 (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella aemnen
ATE22532T1 (de) Pharmazeutische zusammensetzung.
ZA816124B (en) Pharmaceutical compositions for promoting the healing of wounds
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
SE8405588D0 (sv) New compounds
BE885368A (fr) Compositions pharmaceutiques pour le traitement des complications associees au diabete
JPS56138174A (en) Phenylpiperazine derivative of 1,3,4-oxadiazolylphenol, manufacture and medicine containing same
IT1136568B (it) Composizioni per l'idratazione delle sostanze cheratiniche,costutuite da solfossidi di alfa-ammino-acidi
IT8223309A0 (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
DE3161193D1 (en) 5-aminotetrazole derivatives of retinoic acids, their preparation and pharmaceutical compositions containing them
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
IT8319024A0 (it) Composizione medicinale per il trattamento di certe neurovirosi.
RO79428A2 (ro) Compozitie medicamentoasa destinata tratamentului dermatozelor
RO86562A2 (ro) Compozitie vegetala medicamentoasa pentru tratarea unor afectiuni hepato-biliare
EP0039874A3 (de) Methoxsalenzusammensetzungen und deren Herstellung
GR74873B (de)
IL60123A0 (en) Pharmaceutical composition for the treatment of bactericidal infections of the urinary and genital tracts
RO77124A2 (ro) Compozitie medicamentoasa destinata tratamentului aftelor bucale
RO79926A2 (ro) Compozitie medicamentoasa pentru tratamentul hemoroizilor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee